An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate

NCT02187055 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1152

Enrollment

INDUSTRY

Sponsor class

Conditions

Rhematoid Arthritis

Interventions

DRUG: Tofacitinib with methotrexate
DRUG: Tofacitinib without methotrexate
BIOLOGICAL: Adalimumab with methotrexate

Sponsor

Pfizer